Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Onal

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: A Long-Term outcome analysisCem Onal, Gurcan Erbay, Ozan Cem Guler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 28, 2025
Optimizing treatment for Gleason 10 prostate cancer: radiation dose escalation and <sup>68</sup>Ga-PSMA-PET/CT stagingCem Onal, Ozan Cem Guler, Birhan Demirhan, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 3, 2009
Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk dosesCem Onal, Gungor Arslan, Erkan Topkan, et al.
Annals of Nuclear Medicine|March 30, 2020
Retrospective correlation of <sup>68</sup>ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapyCem Onal, Nese Torun, Ezgi Oymak, et al.
Journal of the National Medical Association|August 10, 2006
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancerFadil Akyol, Ugur Selek, Gokhan Ozyigit, et al.
Acta Oncologica (Stockholm, Sweden)|August 26, 2011
Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapyCem Onal, Ayse Kotek, Birsel Unal, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 24, 2008
Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinomaErkan Topkan, Ali A Yavuz, Mehmet Aydin, et al.
The Canadian Journal of Urology|September 5, 2025
National survey of radiotherapy and androgen deprivation therapy strategies with PSMA-PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 studyAysenur Elmali, Birhan Demirhan, Caglayan Selenge Beduk Esen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2021
Stereotactic radiotherapy to oligoprogressive lesions detected with <sup>68</sup>Ga-PSMA-PET/CT in castration-resistant prostate cancer patientsCem Onal, Gokhan Ozyigit, Ezgi Oymak, et al.
Journal of Contemporary Brachytherapy|April 26, 2021
Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology GroupYasemin Bolukbasi, Cem Onal, Zeynep Ozsaran, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2025
Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: A Long-Term outcome analysisCem Onal, Gurcan Erbay, Ozan Cem Guler, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 28, 2025
Optimizing treatment for Gleason 10 prostate cancer: radiation dose escalation and <sup>68</sup>Ga-PSMA-PET/CT stagingCem Onal, Ozan Cem Guler, Birhan Demirhan, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 3, 2009
Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk dosesCem Onal, Gungor Arslan, Erkan Topkan, et al.
Annals of Nuclear Medicine|March 30, 2020
Retrospective correlation of <sup>68</sup>ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapyCem Onal, Nese Torun, Ezgi Oymak, et al.
Journal of the National Medical Association|August 10, 2006
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancerFadil Akyol, Ugur Selek, Gokhan Ozyigit, et al.
Acta Oncologica (Stockholm, Sweden)|August 26, 2011
Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapyCem Onal, Ayse Kotek, Birsel Unal, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 24, 2008
Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinomaErkan Topkan, Ali A Yavuz, Mehmet Aydin, et al.
The Canadian Journal of Urology|September 5, 2025
National survey of radiotherapy and androgen deprivation therapy strategies with PSMA-PET/CT integration in intermediate-risk prostate cancer: TROD 09-007 studyAysenur Elmali, Birhan Demirhan, Caglayan Selenge Beduk Esen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2021
Stereotactic radiotherapy to oligoprogressive lesions detected with <sup>68</sup>Ga-PSMA-PET/CT in castration-resistant prostate cancer patientsCem Onal, Gokhan Ozyigit, Ezgi Oymak, et al.
Journal of Contemporary Brachytherapy|April 26, 2021
Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology GroupYasemin Bolukbasi, Cem Onal, Zeynep Ozsaran, et al.
Pageof 15